Roche Romania reported for the third quarter sales worth over 25.8 million euros, some 30% increase, compared to Q3 in 2005. The total business during the first nine months was over 71 million euros.

Between July and September, the most dynamic products were the transplant, virus and obesity-related drugs, as well as the new products launched on the market, said Dan Zamonea, general manager at Roche Romania. The market share grew from 7.2 to 7.6%, compared to Q3 2005.